Common Stock

9 Months Ended

Feb. 28, 2026

Common Stock [Abstract]

Common Stock

NOTE 7. Common Stock

The Company’s Class A ordinary shares and public warrants trade on the Nasdaq Capital Market under the symbol “HOVR” and “HOVRW”, respectively. Pursuant to the terms of the Company’s Articles and Notice of Articles, the Company is authorized to issue the following shares and classes of capital stock, each with no par value: (i) an unlimited number of Class A ordinary shares; (ii) an unlimited number of Class B ordinary shares; and (iii) an unlimited number of preferred shares. The holder of each ordinary share is entitled to one vote.

As of February 28, 2026, there were warrants outstanding of 12,065,375 at an exercise price of $11.50 USD and 10,000 at an exercise price of $0.75 USD to purchase an equivalent number of Class A ordinary shares.

Warrant holders exercised 3,200,000 warrants in exchange for 3,200,000 Class A ordinary shares for proceeds of $3,282 during the nine months-ended February 28, 2026.

A summary of warrant activity for the Company is as follows:

	Number of Warrants		Weighted Average Exercise Price(USD)		Weighted Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (USD)
Outstanding warrants May 31, 2025		15,275,375	$	9.24		3.7	$	995
Exercised		3,200,000	$	0.75		3.7	$	3,555
Outstanding warrants February 28, 2026		12,075,375	$	11.49		2.9	$	12

In March 2025 the Company filed a shelf registration statement on Form S-3 with the SEC and a related prospectus pursuant to which it may, from time to time, sell shares of its Class A ordinary shares, having an aggregate value of up to $6.25 million USD, pursuant to a Capital on Demand™ Sales Agreement (the “Sales Agreement”) with a placement agent for the sale of its Class A ordinary shares.

On June 27, 2025, the Company filed a prospectus supplement to increase the maximum aggregate offering price of the Class A ordinary shares issuable under the Sales Agreement to $16.5 million USD of Class A ordinary shares. On October 31, 2025, the Company filed an additional prospectus supplement to increase the maximum aggregate offering price of the Class A ordinary shares issuable under the Sales Agreement to $50 million USD of Class A ordinary shares. 

During the three and nine months-ended February 28, 2026, the Company sold 870,297 and 6,874,233 Class A ordinary shares under the Sales Agreement for net proceeds of $2,327 and $21,419, respectively. As of February 28, 2026, the Company had $33.4 million USD remaining eligible for sales under the Sales Agreement.

During the three and nine months-ended February 28, 2026, the Company incurred $21 in general and administrative costs relating to 14,753 Class A ordinary shares to be issued at a future date for services rendered. This has been recorded as a component of Shareholders’ Equity.